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We aimed to perform a chemical analysis of both Alibernet red wine and an alcohol-free Alibernet red wine extract (AWE) and
to investigate the eﬀects of AWE on nitric oxide and reactive oxygen species production as well as blood pressure development
in normotensive Wistar Kyoto (WKY) and spontaneously hypertensive rats (SHRs). Total antioxidant capacity together with total
phenolic and selected mineral content was measured in wine and AWE. Young 6-week-old male WKY and SHR were treated
with AWE (24,2mg/kg/day) for 3 weeks. Total NOS and SOD activities, eNOS and SOD1 protein expressions, and superoxide
production were determined in the tissues. Both antioxidant capacity and phenolic content were signiﬁcantly higher in AWE
compared to wine. The AWE increased NOS activity in the left ventricle, aorta, and kidney of SHR, while it did not change NOS
activity in WKY rats. Similarly, increased SOD activity in the plasma and left ventricle was observed in SHR only. There were
no changes in eNOS and SOD1 expressions. In conclusion, phenolics and minerals included in AWE may contribute directly to
increased NOS and SOD activities of SHR. Nevertheless, 3 weeks of AWE treatment failed to aﬀect blood pressure of SHR.
1.Introduction
Recent ﬁndings have supported the idea that natural bioac-
tive compounds could be beneﬁcial for the prevention and
treatment of cardiovascular disease, although the beneﬁts
for individuals may depend on their genetic proﬁle [1–7].
Among foodstuﬀs widely distributed in the human diet, red
wine has attracted considerable interest as a potential source
of bioactive compounds such as polyphenols and minerals
[8–10].
To date several studies have proposed the mechanisms by
which red wine could exert its beneﬁcial eﬀects toward car-
diovascular disorders and hypertension in particular. These
mechanisms mainly involve increased vasorelaxation and
blood pressure reduction by enhancing nitric oxide syn-
thase (NOS) activity and nitric oxide production [11–15].
Moreover, red wine could modulate activities of endogenous
antioxidant enzymes, thereby enhancing the functions of
body defense against the oxidative stress [16, 17].
Polyphenols and minerals are among the principal
bioactive compounds present in red wines. While red wine
polyphenolic compounds are well known for their direct
free radical scavenging, antioxidant, anti-inﬂammatory, an-
tiplateletaggregation,andlipidmetabolismimprovingactiv-
ities [18, 19], the eﬀects of minerals present in red wines
have been studied much less. Red wine contains a number
of trace elements such as magnesium, zinc, potassium, and
manganese essential for the proper function of endogenous2 Oxidative Medicine and Cellular Longevity
antioxidant system [8, 20]. Mounting evidence suggests that
minerals are able to counteract the development of cardio-
vascular, metabolic and other diseases [21, 22]. The positive
eﬀects of minerals in humans are related to their ability to
enhance the activity of the body’s antioxidant defense system
by catalyzing antioxidant enzymes. For instance, several
minerals found in foodstuﬀs, such as copper, zinc, and
manganese, are essential for activity of superoxide dismutase
(SOD), a key antioxidant enzyme [23, 24].
The modulation of nitric oxide synthase activity seems to
be the most promising tool by which diﬀerent polyphenolic
compounds could regulate the blood pressure. It has been
documented that oral administration of red wine polyphe-
nolic compound can reduce myocardial ﬁbrosis, prevent
aortic thickening, attenuate the increase of aortic reactivity
to norepinephrine, prevent the decrease in acetylcholine-
induced endothelium-dependent relaxation, and, in rats,
reduce blood pressure during NO deﬁciency. These alter-
ations were associated with increased NOS activity, a mod-
erate increase in endothelial NOS expression, and reduction
of oxidative stress, the factors which may be responsible
for the beneﬁcial eﬀect of the red wine polyphenolic
compounds [25, 26]. Moreover, the study of Bern´ atov´ ae t
al. demonstrated that red wine polyphenols (Provinols) even
accelerate the decrease in blood pressure and improved
structural and functional cardiovascular changes produced
in developed form of NG-nitro-L-arginine-methyl-ester (L-
NAME)-induced hypertension [27].
Despite considerable attention paid toward cardiovas-
cular disorders, experimental studies are still lacking. This
study provides comprehensive chemical analysis of both red
wine and red wine extract in order to evaluate the eﬀect
of red wine compounds on NOS and SOD activities, eNOS
and SOD1 expressions, and blood pressure development in
normotensive and spontaneously hypertensive rats.
2.MaterialsandMethods
2.1. Chemicals. Gallic acid, Folin-Ciocalteau reagent, potas-
sium peroxodisulfate, potassium superoxide, Trolox, and
SOD assay kit were obtained from Sigma-Aldrich. The ABTS
assayusedacommercialkitRandoxTASwaspurchasedfrom
Randox Laboratories, Antrim, United Kingdom. Lucigenin
purchased from Fluka. All the other reagents were of analyt-
ical grade.
The wine examined was obtained from the Slovak State
Institute of Viniculture (Modra, Slovakia). Samples of Al-
ibernet red wine were subjected to the process of dealco-
holization, and concentration, producing an alcohol-free ten
times concentrated Alibernet red wine extract (AWE).
2.2. Alibernet Red Wine and AWE Characterization
2.2.1. Measurement of Total Antioxidant Capacity. In the
Alibernet wine and AWE samples, TAC was measured using
spectrophotometric assays on a Thermo Spectronic Genesys
20 UV-visible spectrophotometer (Thermo Fisher Scien-
tiﬁc, Waltham, MA, USA). TAC was determined using a
commercial kit Randox TAS (radical ABTS; Randox Lab-
oratories, Antrim, United Kingdom) according to the
manufacture instructions. Amounts of antioxidant power
are expressed in Trolox (6-hydroxy-2,5,7,8-tetramethylchro-
man-2-carboxylic acid) equivalents (mmol/L).
2.2.2. Measurement of Total Phenolic Content. Total phenolic
content was determined using Folin-Ciocalteau reaction
[28]b ys p e c t r o p h o t o m e t r i ca s s a yo naT h e r m oS p e c t r o n i c
Genesys 20 UV-visible spectrophotometer (Thermo Fisher
Scientiﬁc, Waltham, MA, USA). Absorbance was measured
at 760nm using gallic acid as the standard. TPC is expressed
in gallic acid equivalents (GAEs).
2.2.3. Determination of Minerals. The red wine and AWE
elemental composition was determined by AAS method
using acetylene/argon ﬂame in Atomic Absorption Spec-
trometer (Varian Spectra AA 220 FS, Australia) for copper,
zinc, selenium, and lead, ISE (Ion Selective Electrode) for
potassium determination, and Photometry (Roche equip-
ment, Modular E 170, Switzerland) for calcium, magnesium,
phosphorus, and iron determination.
2.3. Animal Studies
2.3.1. Animals and Treatment. All procedures and experi-
mental protocols were approved by the Ethical Committee of
the Institute of Normal and Pathological Physiology, Slovak
Academy of Sciences, and conform to the European Con-
vention on Animal Protection and Guidelines on Research
Animal Use.
Male 6-week-old normotensive Wistar Kyoto (WKY)
and spontaneously hypertensive rats (SHR) were divided
into the control groups and groups treated with AWE
(24,2mg/kg/day) for 3 weeks (n = 6i ne a c hg r o u p ) .T h e
extract was given in tap water. To ensure that each animal
received the complete amount of AWE, the calculated
amount of liquid extract was given to each cage in the
appropriate volume of water and adjusted to the animal
water consumption. Daily water consumption was estimated
individually for every animal 1 week before the experiment.
During the experiment, water consumption was controlled.
Allanimalswerehousedatatemperatureof22–24◦Candfed
with a regular pellet diet ad libitum. Systolic blood pressure
(SBP) was measured by a noninvasive method of tail-cuﬀ-
plethysmography every week.
After 3 weeks of treatment, the animals were sacriﬁced
and the body weight (BW) and heart weight (HW) were
determined. Samples of the left ventricle, aorta, and kidney
were used to determine NOS and SOD activities and eNOS
and SOD1 protein expressions. Superoxide levels were meas-
uredintheleftventricleandaorta.Totalantioxidantcapacity
and SOD activity were measured also in the plasma.
2.3.2. Total NOS Activity and eNOS Protein Expression. Total
NOS activity was determined in crude homogenates of the
LV, aorta, and kidney by measuring the formation of [3H]-
L-citrulline from [3H]-L-arginine as previously described byOxidative Medicine and Cellular Longevity 3
Bredt and Snyder, with minor modiﬁcations by Pech´ aˇ nov´ ae t
al. [29, 30]. [3H]-L-citrulline was measured with the Quanta
SmartTriCarbLiquidScintillationAnalyzer(PackardInstru-
ment company, Meriden, CT). Total NOS activity is
expressed as pkat/g of proteins.
For eNOS protein expression, samples were prepared
according to Pech´ aˇ nov´ a et al. [31]. Following the electro-
phoresis, proteins were transferred to nitrocellulose mem-
branes and were probed with a polyclonal rabbit anti-eNOS
antibody (Santa Cruz Biotechnology, Inc., USA). Bound
antibody was detected using a secondary peroxidase-con-
jugated anti-rabbit antibody (Santa Cruz Biotechnology,
Inc., USA). The bands were visualized using the enhanced
chemiluminescence system (ECL, Amersham, UK) and ana-
lyzed densitometrically using Photo-Capt V.99 software.
2.3.3. Total SOD Activity and SOD1 Protein Expression. The
SOD activity was analyzed using the SOD assay kit (Fluka).
Theabsorbancewasreadat450nmusingamicroplatereader
(ThermoScientiﬁcMultiscanFC,Finland).SODactivitywas
calculated using activity of SOD standards, and results were
expressed in U/mL in plasma or U/mg of protein in tissues.
For SOD1 protein expression, following the electro-
phoresis, proteins were transferred to nitrocellulose mem-
branes and were probed with a polyclonal rabbit anti-
SOD1 antibody (Santa Cruz Biotechnology, Inc., USA).
Bound antibody was detected using a secondary peroxidase-
conjugated anti-rabbit antibody (Santa Cruz Biotechnology,
Inc., USA). The bands were visualized using the enhanced
chemiluminescence system (ECL, Amersham, UK) and ana-
lyzed densitometrically using Photo-Capt V.99 software.
2.3.4. Total Antioxidant Capacity of Plasma. TAC in plasma
was determined using decolorisation assay and expressed
as trolox equivalent antioxidant capacity (TEAC). Antiox-
idant capacity of samples aﬀect changes in decolorisation
of ABTS radical (3min, 37◦C), measured spectropho-
tometrically at 720nm [32]. Trolox (6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylicacid)wasusedasstandard
and expressed in mmol/L.
2.3.5. Measurement of Superoxide Level. The superoxide
(O2
−) was evaluated using lucigenin-enhanced chemilu-
minscence [33]. The aorta and left ventricle were cut into
small pieces of up to 15mg wet weight. After equilibration
and adaptation to dark conditions, samples were added to
lucigenin solution and measured every 30s for 5min in a
TurnerDesigns TD-20/20luminometer. Resultsareprovided
in relative luminescence unit/mg tissue (RLU/mg tissue).
2.4. Statistics. For Alibernet red wine and AWE characteriza-
tion, data are presented as mean values ± standard deviation
(SD; n = 3). The statistical signiﬁcance was evaluated by
Pearson’s test, which is suitable for small numbers of sam-
ples, using GraphPad Prism version 4 software (GraphPad
Software, San Diego, CA, USA).
For animal studies, one-way analysis of variance and the
Duncan test were used for statistical analysis. Values were
Table 1: Total antioxidant capacity and total phenolic content of
Alibernet red wine and Alibernet wine extract.
Sample TAC mmol/L Total phenols GAE mg/L
Alibernet red wine 35,82 2039 ± 0,55
AWE 376,38 24172 ± 1,26
GAE: gallic acid equivalents, AWE: alibernet red wine extract.
considered to diﬀer signiﬁcantly if the probability value was
less than 0.05 (P<0.05). Results are given as mean ± SD.
3. Results
3.1. Alibernet Red Wine and AWE Characteristics
3.1.1. Total Antioxidant Capacity and Phenolic Content.
AntioxidantcapacityofAlibernetredwinewasslightlyabove
35mmol/L, whereas, in Alibernet wine extract, it reached
376mmol/L. This means that approximately 10 times higher
TAC was determined in AWE in comparison to Alibernet red
wine. The results are visualized in Table 1. This also proves
thattheprocessofextractionhadnotaﬀectedtheantioxidant
properties of the red wine extract.
The total phenolic content of the Alibernet wine samples
determined by the Folin-Ciocalteau colorimetric method
was 2039mg/L in Alibernet wine and above 24172mg/L of
gallic acid equivalents in Alibernet red wine extract.
Our research here establishes that dealcoholised Aliber-
net red wine extract has more than 11-fold higher total
antioxidant capacity and total phenolic content compared to
Alibernet red wine. This conﬁrms that AWE has preserved all
the essential properties of wine. This also reveals a signiﬁcant
positive relationship between total antioxidant capacity and
the total phenolic content.
3.1.2. Mineral Content. The most predominant elements
detected in Alibernet red wineand AWE werepotassium (K),
zinc (Zn), magnesium (Mg), and calcium (Ca). As with TAC
and TPC, wine extract contains up to 10-fold higher values
of these minerals. The results are visualized in Table 2.
3.2. Animal Studies
3.2.1. Animal Characteristics. SHR had signiﬁcantly lower
body weight and higher blood pressure compared to nor-
motensive WKY. Alibernet wine extract treatment failed to
change both body weight and blood pressure of WKY and
SHR. Heart weight did not diﬀer between groups. Results are
shown in Table 3.
3.2.2. Total NOS Activity and eNOS Protein Expression.
The Alibernet wine extract did not change total NOS
activities in the tissues of WKY rats. However, it was able
to increase signiﬁcantly NOS activity in the left ventricle
(Figure 1(a)), aorta (Figure 2(a)), and kidney (Figure 3(a))
ofSHRcomparedtountreatedcontrolrats.EndothelialNOS
protein expression was not changed signiﬁcantly after the4 Oxidative Medicine and Cellular Longevity
Table 2: Elemental proﬁle of Alibernet red wine and Alibernet wine extract (AWE).
Sample K mg/L Mg mg/L P mg/L Ca mg/L Fe mg/L Cu mg/L Se µg/L Pb µg/L Zn mg/L
Alibernet red wine 1387,01 131,14 108,97 69,54 1,54 ND ND ND 354,30
AWE 9069,51 1334,07 ND 657,31 24,60 0,26 ND 7,83 5463,92
Data are expressed as mean values (n = 3). ND: not detected.
Table 3: Animal characteristics: body weight, heart weight, and blood pressure of WKY and SHR.
WKY-C (n = 6) WKY + AWE (n = 6) SHR-C (n = 6) SHR+AWE (n = 6)
Body weight (g) 249 ± 13 253 ± 11 211 ± 12∗ 216 ± 11∗
Heart weight (g) 0,809 ± 0,044 0,841 ± 0,070 0,791 ± 0,046 0,812 ± 0,050
Blood pressure (mmHg) 107 ± 8 108 ± 6 167 ± 12∗ 176 ± 14∗
WKY-C: control Wistar Kyoto rats; WKY + AWE: Wistar Kyoto rats treated with the Alibernet wine extract; SHR-CL: control spontaneously hypertensive rats;
SHR + AWE: spontaneously hypertensive rats treated with the Alibernet wine extract. ∗P<0.05 SHR versus WKY.
AWE treatment in both WKY and SHR (Figures 1(b), 2(b),
and 3(b)).
3.2.3. SOD Activity and SOD1 Protein Expression. The Ali-
bernet wine extract treatment failed to aﬀect SOD activities
as well as SOD1 protein expressions in the tissues of WKY
rats. On the other hand, AWE treatment signiﬁcantly in-
creased SOD activity in the LV of SHR (by 54%; Figure 4(a)).
However, it had no eﬀe c to nl e f tv e n t r i c u l a rS O D 1p r o t e i n
expression (Figure 4(b)). Similarly, AWE treatment failed to
aﬀectSODactivityandSOD1proteinexpressionintheaorta,
kidney, and plasma of SHR (data not shown).
3.2.4. Total Antioxidant Capacity of Plasma. Consistent with
unchangedplasmaSODactivity,therewerenochangesinthe
total antioxidant capacity of plasma in both WKY and SHR
groups after AWE treatment (data not shown).
3.2.5. Measurement of Superoxide Level. Despite an increased
tendency of superoxide level in the left ventricle and
aorta of SHR, there were no signiﬁcant changes between
the strains. Similarly, AWE treatment did not reveal any
signiﬁcant changes in both LV and aorta of Wistar Kyoto and
spontaneously hypertensive rats (Table 4).
4. Discussion
Emerging evidence suggests that minerals as well as polyphe-
nolic compounds could play an important role in the proper
functions of the endogenous antioxidant system as well as
nitric oxide synthase activity.
Here, for the ﬁrst time, an approach of simultaneous
analysisoftotalphenoliccontent,minerals,andantioxidative
capacities was employed to provide complex assessment
of the red wine extract used in the experimental animal
model. It has been conﬁrmed that the Alibernet wine
extract has up to ten times higher amounts of polyphenols
and minerals compared to the Alibernet red wine. These
results allowed us to conclude that processing the wine
to obtain the extract did not have the negative impact
on the content of minerals and phenolics of interest to
present study. Moreover, we conﬁrmed a strong positive
relationship between the total antioxidant capacity and the
content of total phenolic and minerals in both wine and the
wine extract. These results are consistent with the ﬁndings
publishedforredwinesbyotherinvestigators[34,35].Those
authors have experimentally veriﬁed correlation between
polyphenolic content and the total antioxidant activity. In
addition to analysis of polyphenolic content, we have also
studied mineral content, which to a certain extent could
aﬀect the total antioxidant capacity in the red wine extract
as it was shown in Table 1.
Minerals contained in foodstuﬀs play an important role
in the body homeostasis. A growing amount of clinical
evidence indicates relationships between levels of minerals
and progression of certain diseases. Many recent studies
documentedtheabilityofselectedmineralstocounteractthe
developmentofcardiovascular,metabolic,andotherdiseases
[36–40]. Positive eﬀects of minerals in humans are related
to their ability to enhance the activity of antioxidant defense
system by catalyzing antioxidant enzymes. Several minerals
f o u n di nf o o d s t u ﬀs, such as copper, zinc, and manganese,
are essential for proper activity of superoxide dismutase,
a key antioxidant enzyme [41, 42]. Experimental studies
with zinc supplementation have revealed an augmentation
of catalase, glutathione-s-transferase, and SOD activity after
zinc supplementation to rats for 4 months [43].
Since results of chemical analysis of Alibernet wine
extract showed relatively high concentrations of minerals,
this may possibly contribute to changes in the activity of
diﬀerent antioxidant enzymes and/or nitric oxide synthase.
Thus, SOD activity and SOD1 protein expression, NOS
activity,andeNOSproteinexpressionwereanalyzedtogether
in experimental animals after Alibernet wine extract treat-
ment. Western Blot analysis did not shown any signiﬁcant
changes in SOD1 and eNOS protein expressions after AWE
treatment in the tissues investigated. On the other hand,
AWE treatment increased signiﬁcantly SOD activity in left
ventricle and NOS activity in the LV, aorta, and kidney in the
spontaneously hypertensive rats.
Three forms of SOD are present in humans and in all
other mammals: cytoplasmic SOD1, mitochondrial SOD2,
and extracellular SOD3 [44]. SOD1 is a Cu-Zn-dependentOxidative Medicine and Cellular Longevity 5
Table 4: Level of superoxide in the aorta and left ventricle after treatment with AWE.
WKY-C WKY + AWE SHR-C SHR + AWE
Superoxide level in aorta RLU/mg 3,52 ± 1,25 5,66 ± 1,55 6,36 ± 2,47 7,11 ± 1,82
Superoxide level in LV RLU/mg 6,65 ± 1,60 8,12 ± 1,93 7,68 ± 1,67 8,01 ± 2,81
WKY-C: control group; WKY + AWE: animals treated with the Alibernet wine extract;
SHR-C: control group; SHR + AWE: animals treated with the Alibernet wine extract.
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Figure 1: The eﬀect of Alibernet red wine extract (AWE) treatment on total nitric oxid synthase (NOS) activity (a) and eNOS protein
expression (b) in the left ventricle (LV) of Wistar Kyoto rats (WKY) and spontaneously hypertensive rats (SHR). P<0.05 as compared to
respective control. WKY-C: control group; WKY + AWE: animals treated with the Alibernet wine extract; SHR-C: control group; SHR +
AWE: animals treated with the Alibernet wine extract.
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Figure 2: The eﬀect of Alibernet red wine extract (AWE) treatment on total nitric oxid synthase (NOS) activity (a) and eNOS protein
expression (b) in the aorta of Wistar Kyoto rats (WKY) and spontaneously hypertensive rats (SHR). P<0.05 as compared to respective
control. WKY-C: control group; WKY + AWE: animals treated with the Alibernet wine extract; SHR-C: control group; SHR+AWE: animals
treated with the Alibernet wine extract.
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Figure 3: The eﬀect of Alibernet red wine extract (AWE) treatment on total nitric oxid synthase (NOS) activity (a) and eNOS protein
expression (b) in the kidney of Wistar Kyoto rats (WKY) and spontaneously hypertensive rats (SHR). P<0.05 as compared to respective
control. WKY-C: control group; WKY + AWE: animals treated with the Alibernet wine extract; SHR-C: control group; SHR + AWE: animals
treated with the Alibernet wine extract.6 Oxidative Medicine and Cellular Longevity
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Figure 4: The eﬀect of Alibernet wine extract (AWE) on superoxide dismutase (SOD) activity (a) and SOD1 protein expression (b) in the
left ventricle (LV) of Wistar Kyoto rats (WKY) and spontaneously hypertensive rats (SHR). P<0.05 as compared to untreated animals.
WKY-C: control group; WKY + AWE: animals treated with the Alibernet wine extract; SHR-C: control group; SHR + AWE: animals treated
with the Alibernet wine extract.
isoform and is highly upregulated in the endothelial cells
[45]. For this reason, SOD1 protein expression was analyzed.
SinceAWEtreatmentdidnotaﬀectthelevelofSOD1protein
expression, we suppose that elevated level of Zn in AWE
may directly increase SOD activity. We assume there is no
increase in expression of SOD2 or SOD3 proteins after wine
extract treatment. Of course, the polyphenol compounds
involved in the extract may also contribute to increased SOD
activity. These results are consistent with the recent study by
Fern´ andez-Pach´ on et al. [17] where an increased activity of
SOD in human erythrocytes was observed after seven days of
red wine consumption.
Zinc is one of the most important and ubiquitous trace
elements in the body with signiﬁcant antioxidant activity.
Zinc is an important mineral in preventing free radical
formation,protecting biologicalstructuresfromdamageand
boosting the immune response [42, 46]. Moreover, Zhou
et al. [47] have proven the key role of zinc in the proper
function of nitric oxide synthase. In fact, NOS is catalytically
active only as a dimer consisting of two subunits, the as-
sociation of which is stabilized by tetrahedral coordination
of Zn by thiol ligands at the dimer interface. That is why
we also suggest that increased NOS activity after AWE
treatment may be attributed to zinc. Besides zinc, AWE
treatment could also increase the level of calcium—another
important element necessary for endothelial NOS activation
[48]. Our suggestion is conﬁrmed by the fact that Western
Blot analysis did not reveal any signiﬁcant changes in
endothelial NOS protein expression after AWE treatment
of SHR. Thus Zn, Ca, and polyphenol compounds of
AWE most probably directly increased NOS activity. We
assume there is no increase in expression of the neuronal or
inducible NOS proteins in the tissues investigated. L´ opez-
Sep´ ulveda et al. [49] also did not see increased eNOS
expression in the aorta of SHR after red wine polyphenol
treatment. However, several other papers using diﬀerent
models documented increased eNOS expression after red
wine polyphenol administration [15, 25]. We assume that
diﬀerences in polyphenolic consumption, diﬀerent models
as well as diﬀerent treatment duration may be responsible
for diﬀerences in eNOS protein expression.
Our results demonstrating increase in NOS activity in
all samples investigated are consistent with the recent pub-
lications by Auger et al. [13] and Madeira et al. [15]w h e r e
the authors found elevated NOS activity after using diﬀerent
red wine extracts. A recent study of Khoo et al. [50]f o c u s e d
on vascular responses to the polyphenolic compound-
quercetinusingacombinationofbiochemicalandvasoactive
criteria has also conﬁrmed a positive correlation between
quercetin concentration and increased NO bioavailability
in endothelial cells. This study has conﬁrmed the ability
of polyphenolic compounds to improve endothelial cell
function by stimulation of endothelial NOS in nitric oxide
production.
Alibernet red wine extract increased both NOS and SOD
activities only in rats with spontaneous hypertension, where
the abovementioned harmful eﬀects are present. This means
that polyphenols and minerals may aﬀect only pathological
mechanisms while they have no eﬀect under normal condi-
tions. Similar eﬀects of red wine polyphenols were described
in L-NAME-induced hypertension [25]. Nevertheless, in our
study, increased SOD and NOS activities after 3 weeks of
AWE treatment failed to aﬀect blood pressure of SHR.
Theauthorsofseveralpapersonthistopicshowedreduc-
tion of blood pressure after administration of red wine poly-
phenols to SHR. However, duration of the treatment was
generally longer than three weeks. L´ opez-Sep´ ulveda et al.
[49] documented reduction of hypertension and vascular
dysfunction in SHR after red wine polyphenols treatment
(40mg/kg by gavage) for 5 weeks. Chan et al. [51] also
found improved endothelium-dependent dilation after
10-week oral administration of red wine polyphenols
(100mg/kg/day) to SHR. On the other hand, Botden et al.
[52] in a study on humans did not see decreased peripheral
orcentralblood pressureinsubjectswithhigh-normal blood
pressure or grade 1 hypertension after red wine polyphenol
intake at two diﬀerent dosages for 4 weeks. Concerning our
study, increased SOD and NOS activities after 3 weeks of
AWE treatment failed to aﬀect blood pressure of SHR. We
assumethatprolongationofAWEtreatmentcouldleadtothe
reduction of blood pressure as well. This, however, requires
further investigation.Oxidative Medicine and Cellular Longevity 7
In conclusion, our study documented that phenolics
and minerals presented in Alibernet wine extract, and zinc
especially, may contribute directly to increased NOS and
SOD activities in the tissues of spontaneously hypertensive
rats.Thisﬁndingenablesustosuggestthatthepositiveeﬀects
of fruits and vegetables are related to the increase in activity
of the endogenous antioxidant enzymes and enhancement
of antioxidant eﬀects. This occurs together with an increase
in NO production, important for vasodilation and blood
ﬂow improvement. This is particularly important in the case
of hypertension, where elevated free radical and cytokine
production, chronic inﬂammation, and the suppression of
NO production are present.
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